Floatz logo

Ginger

Back Pain

Ferrosan ASPhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Back Pain cohort.

Asset / SponsorPhaseRating
Oxycodone
Grünenthal GmbH
Phase 4BBB
DINITROGEN MONOXIDE
Medical College of Wisconsin
Phase 4BB
PROPOFOL
Medical College of Wisconsin
Phase 4BB
LIDOCAINE
Medical College of Wisconsin
Phase 4BB
NEPENTHE
MedtronicNeuro
Phase 4BB

View all 41 →

Same molecule, other indications

Ginger is also rated in:

cancer of unknown primary siteDormant
B
Indicative ·
57 / 100
View asset →
Nausea and VomitingDormant
B
Indicative ·
57 / 100
View asset →
neuralgiaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →